TIES | $1,500,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Protai
Israel
- Tel Aviv
- 05/01/2022
- Seed
- $8,000,000
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
- Industry Biotechnology Research
- Website https://www.protai.bio/
- LinkedIn https://www.linkedin.com/company/protai-bio/about/
Related People
Eran SegerCo Founder
Israel -
Tel Aviv
My passion lays at the intersection of cutting edge technology and innovative biology. Building on over 15 years of experience in various leadership positions in the High-tech & Cyber field together with my knowledge and passion for the computational-bio space, I co-founded Protai a tech driven drug development computational biology startup.
Protai has built an end-to-end AI-based platform that comprehensively maps the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are discovered.
IC Realtime | $2,000,000 | (Apr 29, 2026)
TrialClinIQ | $150,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)